Atypical Femoral Fractures Following Use of Intravenous Zoledronic Acid After Prior Treatment with Alendronate: A Clinical Practice Series and Opinion
Journal Title: International Journal of Medical and Pharmaceutical Case Reports - Year 2017, Vol 10, Issue 2
Abstract
Aims: An increasing number atypical femoral fractures (AFFs) have been reported in patients who have taken bisphosphonates (BPs) for several years. The European Medicines Agency (EMA) concluded in 2011 that these fractures were a class effect of the drugs. The United States Food & Drug Administration (FDA) updated labels for currently proprietary intravenous Reclast™ (zoledronic acid) have, since 2015, agreed with the EMA opinion. Section 17 of the FDA label states Reclast™ “can cause” these fractures. In this report, we present a clinical sub-class of cases of these fractures illustrating the potential for harm associated with switching BP therapy from an oral agent to Reclast™ (zoledronic acid). Methodology: This paper presents 6 long-term case descriptions of patients, diagnosed with either osteopenia or osteoporosis, incurring a total of ten AFFs following a switch to intravenous zoledronic acid after a much longer and uncomplicated period on oral BPs. One additional case is presented to illustrate that AFFs may also occur with intravenous therapy alone. We have collected these cases directly from the patients and have confirmed all of the details by access to the original medical records, including the radiology and surgery reports. Our opportunity for access is fully described in the article. Results and Opinion: Such a switch has never been investigated in a clinical trial. Based on the pharmacokinetics associated with the intravenous routes for these drugs, we present our reasoning why the untested therapy exemplified should be considered as potentially hazardous. Furthermore, we discuss the reported but rather unremarked wide individual variation in the rate of elimination of intravenously-administered BPs which may be an important factor in determining which individuals are at greatest risk of incurring an AFF.
Authors and Affiliations
W. Banks Hinshaw, Jennifer P. Schneider
Keywords
Related Articles
- EP ID EP310531
- DOI 10.9734/IJMPCR/2017/36791
- Views 82
- Downloads 0
A Case of Sporadic Bilateral Polythelia with High-Grade Myopia
Aim: Polythelia is a rare condition. It ıs known to be associated with urogenital anomalies. Also, there are other types of rare anomalies like hand or mandible anomalies related with this anomaly. However, our case pres...
Bracket Assisted Treatment of Multiple Gingival Recession Using Placental Membrane- A One Year Follow up Case Series
Gingival recession is the apical migration of the junctional epithelium with exposure of the root surface. The treatment of buccal gingival recession is a common requirement due to esthetic concern or root sensitivity. S...
Mauriac Syndrome in a 35 Year Old Woman With Type One Diabetes Mellitus
Mauriac syndrome is a rare complication of type 1 diabetes mellitus. It is characterized by hepatomegaly, growth delay and the presence of elevated transaminases and serum lipids. Mauriac syndrome occurs in males and fem...
De Garengeot Hernia: A Rare Cause of Acute Abdomen
De Garengeot hernia is a femoral hernia with an appendix vermiformis within the hernia sac. It is named after a French surgeon Rene Jacques Croissant de Garengeot, who first described the appendix in the femoral hernia...
Symptomatic Celiac Artery Aneurysm Managed with Celiac Plexus Ablation
A 57-year-old male presented to the ED complaining of severe abdominal pain. Further investigations ruled out gastritis and gastroparesis. Computed tomography (CT) angiography of the abdomen revealed a dissecting aneurys...